Abstract
Alternative treatments, such as traditional Chinese products, plant-derived photosensitizing agents, and herbal and vitamin supplements, can certainly improve therapeutic outcomes in vitiligo.
Traditional Chinese medicine is currently attracting interest in dermatological research looking at the possible development of new drugs. This approach is supported by the political strategies of Western medicine community toward China.
The pro-melanogenic effect may be related to antioxidant or anti-inflammatory properties; however, the main limitation of the published studies concerns the non-complete list of the used products as well as their chemical composition. Similarly, the effectiveness of melagenin is still lacking the knowledge of the underlying mechanisms of repigmentation. On the basis of the in vitro study on immunomodulatory action, aspirin and statins may be considered for the treatment.
More controlled studies should be performed before considering most of the new emerging options based on unconventional drug or combinatory approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cohen BE, Elbuluk N, Mu EW, Orlow SJ. Alternative systemic treatments for vitiligo: a review. Am J Clin Dermatol. 2015;16:463–74.
Jin QX, Wj M, Zs D, et al. Clinical efficacy observation of combined treatment with Chinese traditional medicine and western medicine for 407 cases of vitiligo. Biomed Res. 1983;12:9–11.
Liu ZJ, Xiang YP. Clinical observation on treatment of vitiligo with xiaobai mixture. Chinese J Integr Trad Western Med. 2003;23:596–8.
The Cochrane Collaboration. 2014. http://www.cochrane.org/.
Chen YJ, Chen YY, Wu CY, Chi CC. Oral Chinese herbal medicine in combination with phototherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2016;26:21–7.
Hofer A, Kerl H, Wolf P. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol. 2001;11:225–9.
Ortel B, Tanew A, Honigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol. 1988;18:693–701.
De Leeuw J, Assen YJ, van der Beek N, et al. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol. 2011;25:74–81.
Khemis A, Ortonne JP. Comparative study of vegetable extracts possessing active superoxide dismutase and catalase (Vitix) plus selective UVB phototherapy versus an excipient plus selective UVB phototherapy in the treatment of common vitiligo. Nouvelles Dermatologiques. 2004;23:45–6.
Suite M, Quamina DB. Treatment of vitiligo with topical melagenine - a human placental extract. J Am Acad Dermatol. 1991;24:1018–9.
Xu AE, Wei XD. Topical melagenin for repigmentation in twenty-two child patients with vitiligo on the scalp. Chin Med J. 2004;117:199–201.
Chiu ML, O’Keefe EJ. Placental keratinocyte growth factor: partial purification and comparison with epidermal growth factor. Arch Biochem Biophys. 1989;269:75–85.
Wilkes BM, Susin M, Mento PF. Localization of endothelin-1-like immunoreactivity in human placenta. J Histochem Cytochem. 1993;41:535–41.
Pal P, Roy R, Datta PK, et al. Hydroalcoholic human placental extracts: skin pigmenting activity and gross chemical composition. Int J Dermatol. 1995;34:61–6.
Zhao D, Li Y, Wang P, et al. Melagenin modulates proliferation and differentiation of melanoblasts. Int J Mol Med. 2008;22:193–7.
Maniglia FP, Costa JA. Effects of Acetylsalicylic acid usage on inflammatory and oxidative stress markers in hemodialysis patients. Inflammation. 2015. https://doi.org/10.1007/s10753-015-0244-8.
Berg K, Langaas M, Ericsson M, et al. Acetylsalicylic acid treatment until surgery reduces oxidative stress and inflammation in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2013;43:1154–63.
Zailaie MZ. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo. Saudi Med J. 2004;25:1656–63.
Zailaie MZ. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured melanocytes of active vitiligo. Saudi Med J. 2004;25:1439–44.
Zailaie MZ. Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment. Saudi Med J. 2005;26:799–805.
Zailaie MZ. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients. Saudi Med J. 2005;26:1085–92.
Jian Z, Tang L, Yi X, et al. Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2O2-induced oxidative stress. J Cell Mol Med. 2016;20:1307–18.
Noel M, Gagné C, Bergeron J, et al. Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids Health Dis. 2004;3:7–11.
Namazi MR. Statins: novel additions to the dermatologic arsenal? Exp Dermatol. 2004;13:337–9.
Neuhaus O, Strasser-Fachs S, Fazekas F, et al. Statins as immunomodulators – comparison with interferon-β1b in MS. Neurology. 2002;59:990–7.
Agarwal P, Rashighi M, Essien KI, et al. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol. 2015;135:1080–8.
Tsuji T, Hamada T. Topically administered fluorouracil in vitiligo. Arch Dermatol. 1983;119:722–7.
Sethi S, Mahajan BB, Gupta RR, Ohri A. Comparative evaluation of therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo. Int J Dermatol. 2007;46:875–9.
Anbar TS, Westerhof W, Abdel-Rahman AT, et al. Effect of one session of ERG:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed. 2008;24:322–9.
Gauthier Y, Anbar T, Lepreux S, et al. Possible mechanisms by which topical 5-Fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study. ISRN Dermatol. 2013;2013:852497. https://doi.org/10.1155/2013/852497.
Tsuji T, Karasek MA. Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro. Acta Derm Venereol. 1986;66:474–8.
Morelli JG, Yohn JJ, Lyons MB, et al. Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Investig Dermatol. 1989;93:719–22.
Jeon S, Kim NH, Koo BS, et al. Bee venom stimulates human melanocyte proliferation, melanogenesis, dendriticity and migration. Exp Mol Med. 2007;39:603–13.
Lin Z, Liao Y, Venkatasamy R, et al. Amides from Piper nigrum L. with dissimilar effects on melanocytes proliferation in vitro. Pharm Pharmacol. 2007;59:529–36.
Parsad D, Pandhi R, Dogra S, et al. Topical prostaglandin analog (PGE2) in vitiligo-a preliminary study. Int J Dermatol. 2002;41:942–5.
Kapoor R, Phiske MM, Jerajani HR. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo. Br J Dermatol. 2009;160:861–3.
Anbar TS, El-Ammawi TS, Abdel-Rahman AT, Hanna MR. The effect of Latanoprost on vitiligo: a preliminary comparative study. Int J Dermatol. 2015;54:587–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Picardo, M. (2019). Discussion on Empirical, Traditional, and Alternative Treatments. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_44
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_44
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)